A phase III, multi-centre, randomised placebo-controlled trial of oral iron supplementation for the prevention of maternal anaemia

Research summary

The study hypothesis is that a strategy of universal primary prevention of anaemia during pregnancy with oral iron supplementation will impact the composite primary outcome of pre-term birth,stillbirth,neonatal death and small for gestational age (SGA).

Principal Investigator

Dr Jane Hirst

Contact us

Email: osprea@wrh.ox.ac.uk

IRAS number

1008549